QGEN
QIAGEN NV
NYSE · Healthcare · Medical - Diagnostics & Research · NL
$46.55
+0.91%Forward multiples
Based on analyst estimates
- P/E forward
- 18.37x
- P/E 2026E
- 19.03x
- P/E 2027E
- 17.68x
- P/E 2028E
- 16.18x
- P/S forward
- 4.35x
Trailing multiples
Trailing twelve months
- P/E TTM
- 23.87x
- PEG TTM
- 0.79x
- Price / book
- 2.86x
- Price / sales
- 4.58x
- Price / cash flow
- 14.69x
Enterprise value
- Enterprise value
- $10.5B
- EV / sales
- 4.98x
- EV / EBITDA
- 14.87x
- EV / EBIT
- 19.66x
- Market cap
- $9.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026